The medication appropriateness index at 20: where it started, where it has been, and where it may be going
- PMID: 24062215
- PMCID: PMC3831621
- DOI: 10.1007/s40266-013-0118-4
The medication appropriateness index at 20: where it started, where it has been, and where it may be going
Abstract
Potentially inappropriate prescribing for older adults is a major public health concern. While there are multiple measures of potentially inappropriate prescribing, the medication appropriateness index (MAI) is one of the most common implicit approaches published in the scientific literature. The objective of this narrative review is to describe findings regarding the MAI's reliability, comparison of the MAI with other quality measures of potentially inappropriate prescribing, its predictive validity with important health outcomes, and its responsiveness to change within the framework of randomized controlled trials. A search restricted to English-language literature involving humans aged 65+ years from January 1992 to June 2013 was conducted using MEDLINE and EMBASE databases using the search term 'medication appropriateness index'. A manual search of the reference lists from identified articles and the authors' article files, book chapters, and recent reviews was conducted to identify additional articles. A total of 26 articles were identified for inclusion in this narrative review. The main findings were that the MAI has acceptable inter- and intra-rater reliability, it more frequently detects potentially inappropriate prescribing than a commonly used set of explicit criteria, it predicts adverse health outcomes, and it is able to demonstrate the positive impact of interventions to improve this public health problem. We conclude that the MAI may serve as a valuable tool for measuring potentially inappropriate prescribing in older adults.
Conflict of interest statement
The authors report no potential conflicts of interest.
Similar articles
-
Inappropriate prescribing predicts adverse drug events in older adults.Ann Pharmacother. 2010 Jun;44(6):957-63. doi: 10.1345/aph.1m657. Epub 2010 May 11. Ann Pharmacother. 2010. PMID: 20460558 Clinical Trial.
-
Reducing Potentially Inappropriate Prescriptions for Older Patients Using Computerized Decision Support Tools: Systematic Review.J Med Internet Res. 2019 Nov 14;21(11):e15385. doi: 10.2196/15385. J Med Internet Res. 2019. PMID: 31724956 Free PMC article.
-
Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden.Alzheimers Res Ther. 2017 May 23;9(1):36. doi: 10.1186/s13195-017-0263-9. Alzheimers Res Ther. 2017. PMID: 28535785 Free PMC article. Clinical Trial.
-
Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies).Eur J Clin Pharmacol. 2019 Apr;75(4):451-466. doi: 10.1007/s00228-018-2603-5. Epub 2019 Jan 4. Eur J Clin Pharmacol. 2019. PMID: 30610276 Review.
-
Interventions to improve suboptimal prescribing in nursing homes: A narrative review.Am J Geriatr Pharmacother. 2010 Jun;8(3):183-200. doi: 10.1016/j.amjopharm.2010.05.004. Am J Geriatr Pharmacother. 2010. PMID: 20624609 Free PMC article. Review.
Cited by
-
Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer's Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of Medication Therapy Management Targeting a Delay in Prodromal Dementia Symptom Progression.J Prev Alzheimers Dis. 2022;9(4):646-654. doi: 10.14283/jpad.2022.55. J Prev Alzheimers Dis. 2022. PMID: 36281668 Free PMC article. Clinical Trial.
-
Improvements in Antibiotic Appropriateness for Cystitis in Older Nursing Home Residents: A Quality Improvement Study With Randomized Assignment.J Am Med Dir Assoc. 2021 Jan;22(1):173-177. doi: 10.1016/j.jamda.2020.07.040. Epub 2020 Sep 16. J Am Med Dir Assoc. 2021. PMID: 32948472 Free PMC article. Clinical Trial.
-
Decision support software-guided medication reviews in elderly patients with polypharmacy: a prospective analysis of routine data from community pharmacies (OPtiMed study protocol).J Pharm Policy Pract. 2022 Dec 9;15(1):100. doi: 10.1186/s40545-022-00495-z. J Pharm Policy Pract. 2022. PMID: 36494764 Free PMC article.
-
Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study.BMC Geriatr. 2023 Mar 10;23(1):137. doi: 10.1186/s12877-023-03876-4. BMC Geriatr. 2023. PMID: 36894900 Free PMC article. Clinical Trial.
-
Effect of a Pharmacist-Driven Medication Management Intervention Among Older Adults in an Inpatient Setting.Drugs Aging. 2019 Apr;36(4):371-378. doi: 10.1007/s40266-018-00634-9. Drugs Aging. 2019. PMID: 30671871
References
-
- Spinewine A, Schmader KE, Barber N, Hughes C, Lapane K, Swine C, et al. Appropriate prescribing in elderly people: how can it be measured and optimized? Lancet. 2007;370:173–184. - PubMed
-
- Nelson EA, Dannefer D. Aged heterogeneity: fact or fiction? The fate of diversity in gerontological research. Gerontologist. 1992;32:17–23. - PubMed
-
- Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in elderly inpatients and outpatients. J Am Geriatr Soc. 2001;49:200–9. - PubMed
-
- Knapp DA. Development of criteria for drug utilization review. Clin Pharmacol Ther. 1991;5:600–602. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources